All In MedTech

Device Trial Radar · NCT07800013

Full Core Biopsy Needle vs Side Notch Biopsy Needle

Specimen Quality and Safety of Full-core vs. Side-notch Disposable Biopsy Needles in CT-guided Percutaneous Biopsy: a Single-center Randomized Controlled Study

Last checked: Nov 19, 2026Latest source record: Sep 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

40

Actual

Start

Jul 1, 2025

Primary completion

Mar 1, 2026

Study completion Mar 1, 2026

Sponsor

Lead sponsor
West China HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 2, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Compare the quality of samples collected by the new fully automatic full-core biopsy needle with that of existing biopsy needles, including length, weight, and debris rate

Conditions

  • Biopsy

Interventions

  • Merit Medical CorVocet full-core disposable biopsy needleDevice

    Merit Medical CorVocet full-core disposable biopsy needle

  • Bard Side notch disposable biopsy needleDevice

    Bard Side notch disposable biopsy needle

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Length of specimenTime frame: From enrollment to the end of biopsy at 1 week
  2. MassTime frame: From enrollment to the end of biopsy at 1 week

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • West China hospital

    Chengdu, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.